Market Place
Sourcing Support
Leading Independent Proxy Advisory Firm ISS Recommends BridgeBio Pharma & Eidos
04 Jan 2021 //
BIOSPACE
BridgeBio Pharma and Eidos Therapeutics Announce Merger Agreement
06 Oct 2020 //
GLOBENEWSWIRE
Eidos Therapeutics Appoints Industry Leaders With Significant DevelopmenT
07 Aug 2020 //
GLOBENEWSWIRE
BridgeBio scraps plan to buy Eidos after bids rebuffed
15 Oct 2019 //
FIERCE BIOTECH
Plotting toe-to-toe with Pfizer, Eidos plans score in PhIII ATTR-CM study
28 Feb 2019 //
ENDPTS
EU green light for Cimzia to treat psoriasis
03 Jul 2018 //
PHARMA TIMES
Eidos Therapeutics raises $106M IPO to advance ATTR med
20 Jun 2018 //
FIERCE BIOTECH
Eidos Therapeutics Announces Pricing of Initial Public Offering
19 Jun 2018 //
PR NEWSWIRE
Rare disease biotech Eidos Therapeutics sets terms for $100 million IPO
08 Jun 2018 //
NASDAQ
Copyright © 2025 LePro PharmaCompass OPC Private Limited, All rights reserved.